date,action,name,rate,target
Dec-13-18,Initiated,Goldman,Neutral,$25
Dec-14-18,Initiated,Wolfe Research,Outperform,
Mar-21-19,Initiated,ROTH Capital,Buy,$75
Mar-28-19,Initiated,Robert W. Baird,Outperform,$80
Apr-26-19,Upgrade,Goldman,Neutral to Buy,$25 to $55
Apr-26-19,Reiterated,Chardan Capital Markets,Buy,$85 to $90
